Matches in Wikidata for { <http://www.wikidata.org/entity/Q89933505> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- Q89933505 description "article scientifique publié en 2017" @default.
- Q89933505 description "articolo scientifico (pubblicato il 2017)" @default.
- Q89933505 description "artikull shkencor i botuar më 01 shkurt 2017" @default.
- Q89933505 description "artículu científicu espublizáu en febreru de 2017" @default.
- Q89933505 description "im Februar 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q89933505 description "scientific article published on 01 February 2017" @default.
- Q89933505 description "wetenschappelijk artikel" @default.
- Q89933505 description "наукова стаття, опублікована в лютому 2017" @default.
- Q89933505 name "Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363]" @default.
- Q89933505 name "Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363]" @default.
- Q89933505 name "Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363]" @default.
- Q89933505 type Item @default.
- Q89933505 label "Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363]" @default.
- Q89933505 label "Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363]" @default.
- Q89933505 label "Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363]" @default.
- Q89933505 prefLabel "Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363]" @default.
- Q89933505 prefLabel "Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363]" @default.
- Q89933505 prefLabel "Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363]" @default.
- Q89933505 P1433 Q89933505-91AAC264-20D9-4AE2-8D36-798A2A174AC3 @default.
- Q89933505 P1476 Q89933505-DC10BDB1-9E96-4190-B5F2-0DD5D4FA4CE9 @default.
- Q89933505 P2093 Q89933505-22C729F9-67AE-4471-AB9D-DD7578FA503A @default.
- Q89933505 P2093 Q89933505-3D95F2BA-E054-4537-A224-496B1D527CB5 @default.
- Q89933505 P2093 Q89933505-769A30CD-5872-4EBD-AF8A-111D665D5798 @default.
- Q89933505 P2093 Q89933505-D2426BBB-FDB8-47A3-A6BC-B5A3697A6DA8 @default.
- Q89933505 P2093 Q89933505-EF7242D2-36B6-4A0B-9622-3DA276A9066C @default.
- Q89933505 P304 Q89933505-A4686F82-4CED-49A1-81D0-757DAC65789E @default.
- Q89933505 P31 Q89933505-6771B971-F2F9-4A0A-9C5E-B0F8790CC6DB @default.
- Q89933505 P31 Q89933505-E62A6D79-D661-4A62-A9D4-E769D455A658 @default.
- Q89933505 P356 Q89933505-51A562A2-7564-4E5E-BB89-0212196F6EEE @default.
- Q89933505 P433 Q89933505-5D825B9C-B2F9-4537-80AE-214CAE6700F5 @default.
- Q89933505 P478 Q89933505-FDE7FB1A-1859-4A59-8A27-0C5B52A76095 @default.
- Q89933505 P577 Q89933505-218D9646-AF4D-494D-A1EB-9E9A5065E41C @default.
- Q89933505 P698 Q89933505-0E4026B0-3F73-4E73-A56A-5FB4334289CA @default.
- Q89933505 P921 Q89933505-BE725BBD-296B-4DAF-84DF-913477DA89D6 @default.
- Q89933505 P356 J.YGYNO.2016.10.034 @default.
- Q89933505 P698 28089052 @default.
- Q89933505 P1433 Q5625182 @default.
- Q89933505 P1476 "Corrigendum to 'Equivalency challenge: evaluation of Lipodox® as the generic equivalent for Doxil® in a human ovarian cancer orthotropic mouse model' [Gynecol. Oncol. 141 (2016) 357-363]" @default.
- Q89933505 P2093 "Judith A Smith" @default.
- Q89933505 P2093 "Lata Mathew" @default.
- Q89933505 P2093 "Maryam Burney" @default.
- Q89933505 P2093 "Pranavanand Nyshadham" @default.
- Q89933505 P2093 "Robert L Coleman" @default.
- Q89933505 P304 "448" @default.
- Q89933505 P31 Q13442814 @default.
- Q89933505 P31 Q1348305 @default.
- Q89933505 P356 "10.1016/J.YGYNO.2016.10.034" @default.
- Q89933505 P433 "2" @default.
- Q89933505 P478 "144" @default.
- Q89933505 P577 "2017-02-01T00:00:00Z" @default.
- Q89933505 P698 "28089052" @default.
- Q89933505 P921 Q172341 @default.